Strategic Advocates’s iShares 10+ Year Investment Grade Corporate Bond ETF IGLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.55K Buy
71
+66
+1,320% +$3.29K 0.01% 191
2026
Q1
$248 Sell
5
-7
-58% -$354 ﹤0.01% 256
2025
Q4
$609 Hold
12
﹤0.01% 538
2025
Q3
$618 Buy
+12
New +$605 ﹤0.01% 514
2024
Q4
Sell
-10,044
Closed -$538K 117
2024
Q3
$538K Buy
10,044
+3,786
+60% +$198K 0.19% 71
2024
Q2
$313K Sell
6,258
-15,444
-71% -$772K 0.12% 92
2024
Q1
$1.12M Sell
21,702
-122,972
-85% -$6.31M 0.43% 44
2023
Q4
$7.62M Sell
144,674
-82,732
-36% -$4M 3.24% 7
2023
Q3
$10.7M Buy
+227,406
New +$11.3M 5.05% 4

Other funds holding IGLB

Strategic Advocates's IGLB Position: Q2 2026 in Review

Strategic Advocates increased its iShares 10+ Year Investment Grade Corporate Bond ETF (IGLB) stake by 1,320% in Q2 2026, buying an estimated $3.29K and bringing the position to 71 shares worth $3.55K. The position accounts for 0.01% of the portfolio, ranked #191.

Strategic Advocates first reported a position in IGLB in Q3 2023 and has held it in 9 quarters since. The position peaked at $10.7M in Q3 2023. 215 funds tracked by Wall St. Rank hold IGLB as of Q2 2026.

  • Strategic Advocates held 71 shares of iShares 10+ Year Investment Grade Corporate Bond ETF worth $3.55K as of Q2 2026.
  • Strategic Advocates bought 66 iShares 10+ Year Investment Grade Corporate Bond ETF shares in Q2 2026, an estimated $3.29K.
  • iShares 10+ Year Investment Grade Corporate Bond ETF made up 0.01% of Strategic Advocates's portfolio in Q2 2026, its #191 holding.
  • Strategic Advocates first reported a position in iShares 10+ Year Investment Grade Corporate Bond ETF in Q3 2023 and has held it in 9 quarters since.
  • Strategic Advocates's iShares 10+ Year Investment Grade Corporate Bond ETF position peaked at $10.7M in Q3 2023.
  • 215 funds tracked by Wall St. Rank held iShares 10+ Year Investment Grade Corporate Bond ETF as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.